Emirates Pathology UCGConferences

  Biography : Dr Pradeep Kumar Kar, has a vast experience in the field of oncology, molecular pathology digital pathology and related areas. He has worked for esteemed organisations like JIMPER, Kidwai Memorial Institute of Oncology, Fortis Cancer Institute and Farcast Biosciences. In his most recent role as a molecular pathologist at the Biocon Brystol Myers Sqibb Research and Development Center (BBRC), he has focused on Digital Pathology, and Various complex monoplex and Multiplex assay and algorithms development along with understanding the role of Tumor Microenvironment in IO (Immuno-Oncology) drug response and registance in various cancer types. Dr Pradeep has completed MD in Pathology from VSS Medical college and Fellowship in Oncopathology at Kidwai Memorial Cancer Institute, Bangalore. He has published several research papers and also Taught pathology at JIMPER in pondicherry and Kidwai Memorial Cancer Institute. ----------------- Integrating Pathology and Genomics as a

Speaker Biography:  Dr. Bahareh Arbabi , a dedicated OBGYN and board- certified cosmetic gynecologist from Iran, has been making waves in her field for over a decade. With a remarkable record of 3000+ deliveries and 800 successful cosmetic gynecology surgeries, she stands as a shining star in the world of women’s health. Dr. Bahareh has earned prestigious Fellowship in Stem Cell and Regenerative Medicine from IASRM India and Fellowship in Cosmetic Gynecology from ABCG. She is also a faculty member in a Cosmetic Gynecology course in Dubai showcasing her dedication to education. Dr. Bahareh has graced stages around the globe, sharing her expertise at events like the ISRAM World Congress 2023 in India Aptos Company event Georgia, ESAG London, and the IMCAS World Congress Paris 2024. Her influence extends to her membership in ISSM (Sexual Medicine) in Dubai. In her homeland, Dr. Arbabi serves as the Head of the Cosmetic Gynecology Department and holds the esteemed position of a univer

Bladder cancer is a type of cancer that begins in the cells of the bladder, the organ responsible for storing urine. Understanding the symptoms of bladder cancer is crucial for early detection and effective treatment. In this blog, we’ll discuss the key symptoms to watch for, risk factors, and when to seek medical advice. Common Symptoms of Bladder Cancer Hematuria (Blood in the Urine) : Visible Blood : One of the most common and early signs of bladder cancer is hematuria, or blood in the urine. It may appear pink, red, or cola-colored. Microscopic Hematuria : Sometimes, the blood is not visible to the naked eye and can only be detected through a urine test. Frequent Urination : An increased need to urinate, especially at night, can be a symptom of bladder cancer. This urgency may occur even when the bladder is not full. Painful Urination : Discomfort or a burning sensation during urination can be a

Immunohistochemistry (IHC) is a powerful and essential tool in the world of pathology and biomedical research. This technique allows scientists and clinicians to visualize the distribution and localization of specific proteins within tissue sections, providing crucial insights into disease mechanisms, diagnostics, and treatment strategies. Whether you're a seasoned pathologist, a medical student, or just curious about the intricacies of medical science, understanding IHC can offer a fascinating glimpse into the microscopic world of tissues and cells.   What is Immunohistochemistry? At its core, IHC is a method used to detect specific antigens (proteins) in tissue sections by leveraging the principle of antibodies binding specifically to these antigens. This interaction is then visualized through various labeling techniques, allowing us to see where these proteins are located within the tissue. The IHC Process: A Step-by-Step Guide Fixation : The first step involves preservin